The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients

Figure 2

Functional outcomes at 90 days in the target and nontarget groups of patients with CAEs, according to score on the Modified Rankin Scale.